Image

Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy

Investigational Medication Niraparib Plus Ipilimumab for Metastatic Pancreatic Adenocarcinoma

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates metastatic pancreatic adenocarcinoma. The purpose of this study is to evaluate the investigational medication plus ipilimumab in patients whose condition has not worsened on previous chemotherapy.

The study evaluates the effectiveness and safety of the investigational medication combined with ipilimumab. It looks at how these treatments work together in managing the condition.

  • Who can participate: Adults aged 18 and older with metastatic pancreatic adenocarcinoma may join. Participants should meet certain health criteria.
  • Study details: Participants will receive the investigational medication niraparib plus ipilimumab or standard chemotherapy.
Print
Study details
    Pancreatic Adenocarcinoma Metastatic

NCT06747845

Abramson Cancer Center at Penn Medicine

17 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.